Schwann cells' (SCs) development and maturation require coordinate and complementary activation of several signals and intracellular pathways. Among factors controlling these processes, the signalling intermediates Src tyrosine kinase and focal adhesion kinase (FAK) are relevant for SCs', participating in regulation of their adhesion, motility and migration. Recently, the progesterone metabolite allopregnanolone (ALLO) was proved to be synthesized by SCs, whereas it acts autocrinally on SCs motility and proliferation, which are crucial processes for nerve development, maturation and regeneration. Herein, we investigate the hypothesis that the molecular mechanisms behind the ALLO's action on SCs involve the signalling intermediates Src and FAK. We first demonstrated that ALLO 10 À6 M regulates SCs morphology, motility and myelination, also increasing the internode distance in the in vitro myelination model of neuron/SCs co-culture. ALLO's actions were mediated by the modulation of Src/FAK pathway, since they were counteracted by PP2 10 À5 M, a selective inhibitor of Src kinase. Then, we proved that Src/FAK activation in SCs involves GABA-A dependent mechanisms and actin re-arrangements. In conclusion, our findings are the first to corroborate the importance of the neuroactive steroid ALLO in regulating SCs development and maturation via the Src and phospho-FAK signalling activation.
The non-receptor-type tyrosine kinase Src is a crucial component of some signal transduction pathways implicated in a wide range of cellular processes, including cell growth, migration and differentiation (Zhao et al. 2003) . Src is highly enriched in the developing axons of the central nervous system (CNS) and PNS (Sorge et al. 1984; Fults et al. 1985) , suggesting that Src is an important signal transducer for axonal outgrowth. In the PNS, the Src activity is increased during nerve regeneration (Le Beau et al. 1991; Zhao et al. 2003) , whereas it enhances axon-SCs contact for nerve regrowth. Indeed, Src is largely expressed in the SCs distal from a nerve injury, decreasing with restoration of axon-SCs cross-talk (Zhao et al. 2003) . However, the molecular mechanism regulating the Src functions in SCs has not been fully investigated.
FAK is another non-receptor protein tyrosine kinase, controlling cell motility and focal adhesion sites turnover Sanchez et al. 2011) . FAK is relevant for SCs, being involved in regulating their proliferation, survival and differentiation (Grove et al. 2007; Grove and Brophy 2014) . In the absence of FAK, the developing SCs proliferate poorly, sort axons inefficiently and cannot myelinate peripheral nerves. FAK is required in vivo for SCs' contractility and radial sorting (Grove et al. 2007) . Recent in vitro studies emphasized the requirement of FAK for promoting SCs spreading and polarization (Grove and Brophy 2014) . FAK phosphorylation at Tyr397 is an early event, serving to expose a docking site for Src (Schaller et al. 1994; Xing et al. 1994) . Then, Src phosphorylates some sites in FAK, including two in the kinase domain, in turn promoting optimal FAK activation (Calalb et al. 1995) . Therefore, the mutual phosphorylation between Src and FAK might be a mechanism of potentiation of SCs cellular processes.
Neuroactive steroids, including progestagens, are hormones synthesized and active in the nervous system. The progesterone metabolite 5a-pregnan-3a-ol-20-one, named tetrahydroprogesterone or allopregnanolone (ALLO), is the most important neuroactive steroid (Baulieu and Robel 1990) , targeting both neurons and glial cells in the CNS as well as in the PNS. ALLO acts through c-amino butyric acid (GABA) type A (GABA-A) receptor, via non-genomic action, albeit alternative mechanisms have been recently hypothesized (Cooke et al. 2013; Puia et al. 2015) . PNS is also considered a steroidogenic tissue, having the capability to synthesize and metabolize ALLO, as much as of expressing the classic progesterone (PR) and the GABA-A receptors (Faroni and Magnaghi 2011; Melcangi et al. 2011) .
In the PNS, ALLO participates in the control of myelination, nociception and nerve regeneration (Magnaghi et al. 2006a (Magnaghi et al. , 2010 Faroni and Magnaghi 2011; Patte-Mensah et al. 2014) . SCs synthesize ALLO and simultaneously may be a target of its actions (Faroni and Magnaghi 2011 ). ALLO's actions are part of complicated mechanisms, involving the GABA synthesis, as well as the sequential activation of both GABA-A and GABA type B (GABA-B) receptors, specifically located on the SCs membrane (Faroni and Magnaghi 2011; Procacci et al. 2012) . Via a rapid protein kinase A (PK-A)-dependent autocrine loop, ALLO stimulates the GABA synthesis in SCs, providing the specific ligand for GABA-A receptor activation (Magnaghi et al. 2010) . ALLO up-regulates SCs proliferation in vitro and this effect is mediated by the excitatory aminoacid transporter 1 (EAAC1). Through a GABA-A-mediated protein kinase C (PK-C)-dependent activation, indeed, ALLO induces a rapid regulation of the EAAC1 activity in SCs (Perego et al. 2012) . EAAC1 delivery at the SCs membrane is prevented by actin depolymerization, suggesting that EAAC1 participates in the control of the rapid ALLO-mediated effects on SCs morphology and proliferation (Perego et al. 2012) . These controls are likely exerted because ALLO promotes the selective EAAC1 binding to those proteins tethering the transporter to the actin cytoskeleton. Overall, ALLO exerts roles in controlling SCs' motility and proliferation, which are crucial processes for nerve development, maturation and regeneration.
In general, the protein f-actin forms a polymer that lies beneath the plasma membrane (Pollard and Borisy 2003) and in the lateral microvilli of SCs (Trapp et al. 1989) , highlighting their cellular perimeter. The rearrangement of actin cytoskeleton is critical for SCs differentiation and myelination (Fernandez-Valle et al., 1997; Gatto et al., 2003) . Indeed, along differentiation the SCs reorganize the f-actin cytoskeleton, presenting bundles of stress fibres (Li et al. 2003) . As a consequence, SCs change from a flat into a bipolar spindle-shaped phenotype, resembling the cells starting the myelination process in vivo. Recently, the colocalization of GABA-B receptors with f-actin was found on the SCs elongated processes, whereas the SCs assume the typical spindle-shaped morphology. This also emphasizes the participation of the GABA receptors in regulating the myelination process in vivo (Procacci et al. 2012) .
Although ALLO and Src/FAK disclosed important roles in cell growth, migration and proliferation, to our knowledge no studies were aimed to investigate their cross-regulation. Even less, the Src/FAK signalling cascade was studied in glial cells, neither in CNS nor in PNS. However, in principle, the kinases Src/FAK might be implicated in the SCs functions of the PNS. FAK was the only factor shown to be required for SCs proliferation, spreading and differentiation (Grove et al. 2007; Grove and Brophy 2014) , although it appeared unnecessary to adult SCs, neither for myelin maintenance nor for re-myelination after sciatic nerve crush (Grove and Brophy 2014) .
In this study, we investigate the hypothesis that the molecular mechanisms behind the ALLO's activation of the signalling intermediates kinases Src and FAK may contribute to the regulation of the SCs proliferation [previously observed in (Perego et al. 2012) ], as well as to the control of SCs motility, morphological rearrangements and myelination processes. Our results proved the importance of ALLO in regulating SCs, suggesting that its action is mostly mediated by GABA-A receptor and Src/FAK activation. These mechanisms may be pharmacologically relevant for the development of new therapeutic approaches for the peripheral neuropathies.
Material and methods

Primary SCs culture
Rat SCs cultures were obtained by the method of Brockes (Brockes et al. 1979 ) with minor modifications (Magnaghi et al. 2007) . Sciatic nerves from 3-day old rats were digested with 1% collagenase and 0.25% trypsin (Sigma, Italy), then filtered through a 30 lm nylon membrane and centrifuged 10 min at 280 g. Pellets were suspended in Dulbecco's modified Eagle's medium (DMEM, Serotec, Oxford, UK) plus 10% foetal calf serum (FCS, Gibco-Life Technologies, Italy) and were plated on 35 mm Petri dishes. After 24 h, the medium was supplemented with 10 lM arabinoside C (Sigma) then after 48 h the cultures were treated with a stream of cold DMEM-FCS 10%. The remaining cells were plated in DMEM-FCS 10% plus 10 lM forskolin (Sigma) and 200 lg/mL bovine pituitary extract (BPE, Invitrogen, San Giuliano Milanese, Milan, Italy) . Cells became confluent in 10 days. Immunopanning for final purification was carried out incubating the cells 30 min with mouse anti rat Thy1.1 antibody (Serotec, Italy) followed by 500 lL of baby rabbit complement (Cedarlane, Canada). Cell suspension was seeded on 60 mm Petri dishes (9 9 10 4 cells/Petri) or multiwell plates (see below), maintained in DMEM, 10% FCS, 2 lM forskolin, 200 lg/ mL BPE. At third in vitro passage, SCs were treated for 48 h with 4 lM forskolin, then used for different assays. At the time experiments begun SCs had equal cell densities.
Dorsal root ganglia (DRG) neuron primary cultures
Rat DRG neurons were obtained as previously described (Mauro et al. 2013) . Briefly, DRG were harvested and dissociated for 2 9 1 h in 0.125% (w/v) collagenase type IV (Worthington, Lakewood, NJ, USA) in F12 (Invitrogen), then incubated 30 min in 0.25% trypsin (w/v) (Worthington, NJ, USA) in F12. After trypsin inactivation, DRGs were washed, mechanically dissociated, filtered and centrifuged (200 g 9 5 min). The bolus of dissociated neurons was re-suspended in modified Bottenstein and Sato's medium (BS medium) containing 0.1 mg/mL transferrin, 20 nM progesterone, 100 lM putrescine, 30 nM sodium selenite, 1 mg/mL bovine serum albumin (BSA), 0.01 mM cytosine arabinoside, 10 pM insulin (all Sigma). Neurons were seeded onto dishes precoated with 2 lg/mL laminin and polylisin 2 lg/mL (Sigma). Rat SCs and neuron primary cultures were obtained following current Italian and European rules concerning care and use of animals (D.Lvo. no. 26, 4 March 2014; Directive 2010/63/EU) and according to 3R's guidelines on the use of animals.
DRG and SCs co-culture and in vitro myelination
Co-culture were set up on polylysine 100 lg/mL -laminin 2 lg/mL coated petri dishes, in the presence of nerve growth factor (NGF) 50 ng/mL. To this end, SCs grown for 3 days in vitro (DIV) were then trypsinized, suspended in F12 plus 10% fetal bovine serum (FBS), forskolin 2 lM and plated (2 9 10 4 cells/well) in a 24-multiwell; higher density SCs were necessary to allow a carpet of supporting cells, on which neurons take advantage for surviving. Two days after, DRG neurons were plated on the SCs, the medium was changed with the differentiating medium: F12 plus DMEM (50-50%), FBS 2.5%, Fsk 4 lM, 19 N2 complement (Gibco-Life Technologies), insulin 10 pM, NGF 50 ng/mL. Then, after 5 DIV, cells were incubated in myelinating medium: F12 plus DMEM, FBS 2.5%, 1X N2 complement, insulin 10 pM, NGF 50 ng/mL, glial growth factor (GGF) 126 ng/mL, ascorbic acid 1 mg/mL. Medium was changed every 3 days. Then, cells were maintained in myelination medium for 21 days before processing for light microscopy (using a Axiovert 200, Zeiss, Germany) or immunofluorescence (IFL) analysis; during that time, co-culture were treated once a day, respectively, with 10 À6 M ALLO or 10 concentration of GABAergic agonist/antagonist were chosen based on previous experience (Magnaghi et al. 2001; Perego et al. 2012) .
To analyse the role of actin dynamics, the SCs were incubated for 1 h with cytochalasin D 2 9 10 À6 M before a 30 min ALLO incubation.
All drugs were from Sigma. Controls cultures were treated with vehicle (ethanol).
Long-term SCs culture assay
To test the long-term effect of ALLO and PP2, that is the involvement of Src, the SCs cultures were plated as described above (9 9 10 4 cells/ Petri), then treated with 10 À6 M ALLO or 10 À6 M ALLO plus 10 À5 M PP2, respectively, and analysed at 6 DIV. Light microscopy images were taken with a Axiovert 200, Zeiss microscope.
SCs migration assays
Wound-healing assay was performed by making a scratch on the bottom of the Petri (containing SCs plated as described above, 9 9 10 4 cells/Petri), then the medium was changed with fresh medium plus mitomycin 50 ng/mL (Sigma) to counteract cell proliferation and the cells exposed to 10 À6 M ALLO or 10 À6 M ALLO plus 10 À5 M PP2 respectively. Cells were then photographed with a scanning microscope (Axiovert 200, Zeiss) at different time points: 2, 6, 24 and 48 h after the scratch (t = 0). Pictures were acquired using MetaVue software and the distances between cell fronts were measured with Image-ProPlus 6.0 (MediaCybernetics, MA, USA), considering at least nine measurements from the top to the bottom.
Migration was also tested by Boyden assay (chemotaxis) using a 48-well Boyden's chamber, according to manufacturer's instructions (Neuroprobe, Gaithersburg, MD, USA). Cells were exposed for 24 h to treatments with 10 . For quantitative analysis, cells were counted using a 409 objective on an optical microscope. Three random objective fields were counted, for each well, and the mean number of migrating cells was calculated.
IFL analysis
SCs were seeded on slides in 12-multiwell plates (15 9 10 3 cells/ well), treated for 24 h with 10 À6 M ALLO or 10 À6 M ALLO plus 10 À5 M PP2, then fixed in 4% paraformaldehyde and processed for immunostaining. SCs purity (more than 98%) was tested with a specific antibody against glycoprotein P0 (Magnaghi et al. 2007 ). Phalloidin-FITC staining of f-actin (1 : 250, Sigma) was used to reveal SCs cytoskeleton. Slides were incubated overnight at 4°C in PBS, 0.25% BSA, 0.1% Triton X-100 and the specific primary antibody. The following day, slides were washed and mounted using Vectashield TM (Vector Laboratories, Burlingame, CA, USA).
Nuclei stained with 40,6-diamidino-2-phenylindole (Dapi). DRG neurons were characterized by IFL against neurofilament of 200 kDa (NF200, Sigma or SMI31-SMI32, Covance, Priceton, NJ, USA), as described (Mauro et al. 2013 ). In the co-culture experiments, cells were treated as described above, once a day for 21 days with ALLO alone or ALLO plus 10 À5 M PP2, then fixed in 4%
paraformaldehyde. Cells were then incubated overnight at 4°C in PBS, 0.25% BSA, 0.1% Triton X-100 and the specific primary antibodies: SMI31-SMI32 (1 : 600) and the specific SCs marker myelin basic protein (1 : 200; Abcam, Cambridge, UK). The following day, the cells were incubated 2 h at 21°C, respectively, with specific Alexa-488 or Alexa-594 secondary antibodies, (1 : 800, Life Technologies). After washing, nuclei were stained with Dapi and coverslips mounted with Vectashield. Controls for the specificity of antibodies included a lack of primary antibodies. Confocal microscopy was carried out using a Zeiss LSM 510 System (Oberkochen, Germany) and images were processed with Image Pro-Plus 6.0.
Measurement of internode distance in co-cultures was carried out on images at 63 9 magnification (3 samples, 5 fields each sample, total N = 15) and the mean length of segments was calculated in pixels, then calibrated in microns (1 pixels = 10.58 microns).
Western blot analysis SCs were plated as described above (9 9 10 4 cells/Petri), then after 30 and 60 min treatments (as described above), SCs were collected on ice with lysis buffer containing 50 mM Tris-HCl, pH 7. 
Statistics
Experiments were repeated at least three times. Each experimental group (after power analysis) was set at: N = 3 for migration and chemotaxis assays; N = 6 for western immunoblots quantification; N = 3, 5 field each sample, total N = 15 for co-culture/myelination analysis. All data were presented as mean AE SEM. Statistical analysis was performed using GraphPad Prism 6 (CA, La Jolla, CA, USA). Statistical differences between means were analysed using unpaired Student's t-test, one-way or two-way ANOVA, with Tukey's multiple comparison post hoc test, depending of outcomes analysed. Differences at p values < 0.05 were considered significant.
Results
ALLO regulates SCs morphology and motility
Data previously collected in our and other laboratories demonstrated that ALLO increases SCs' proliferation, mostly via GABA-A mediated mechanisms (Faroni et al. 2012; Perego et al. 2012 ). Here we found that in vitro treatment with ALLO 10 À6 M induced SCs morphological rearrangements, giving to these cells the capability to assume the typical spindle-shaped morphology (Fig. 1a) . This effect was counteracted by the co-treatment with PP2 10 À5 M, a selective inhibitor for Src kinase [PP2 10 À5 M concentration was chosen on the base of previous experiments (Zheng et al. 2012) ]. Indeed, SCs co-treated with ALLO and PP2 for 24 h showed different morphology, resembling flattened cells (Fig. 1a) . This data suggested the involvement of Src signalling cascade in the control of the ALLO-induced changes in SCs morphology. A direct involvement of Src was further corroborated by phalloidin IFL assay. ALLO proved able to enhance the typical spindle-shaped morphology of SCs, as shown by stress fibres immunostaining (Fig. 1b , central panels and Fig. S1 ). Moreover, ALLO induces formation of radial lamellipodia in SCs (Fig. 1b , central panels and Fig. S1 ). The simultaneous PP2 cotreatment changed the SCs morphology towards an enlarged and flattened phenotype, in which the lamellipodia were significantly reduced (Fig. 1b , lower panels and Fig. S1 ), still suggesting a strong involvement of Src in the ALLOregulated SCs adhesion. Furthermore, to test the long-term effects of ALLO and PP2 (i.e. Src involvement) on morphology and adhesion, the SCs cultures were treated and analysed at 6 DIV. Exposure to ALLO 10 À6 M still promoted the growth and the characteristic spindle-shaped morphology (Fig. 1c) , whereas the SCs culture exposed simultaneously to ALLO and PP2 10 À5 M appeared suffering and decreased in number (Fig. 1c) . Then, it was deemed of interest to analyse whether ALLO may control the SCs migration. To assess this hypothesis, we designed a wound-healing assay on a SCs monolayer treated with ALLO 10 À6 M. A great number of SCs were able to repopulate the wounded region within 24 h (Fig. 2b) , achieving a complete closure of the two sides at later time, 48 h (Fig. S2) . ALLO 10 À6 M exposure induced a stimulation of SCs migration (Fig. 2b) versus controls (Fig. 2a) , that was significantly increased (p < 0.001; F = 30.72) at 2, 6 and 24 h after treatment (Fig. 2d) . This effect was significantly blocked (p < 0.001; F = 30.72) by the simultaneous co-treatment with PP2 10 À5 M (Fig. 2c) , versus controls ( Fig. 2a) , confirming that ALLO's stimulation might be via Src activation. Furthermore, a 24-h ALLO treatment induced a significant increase (p < 0.001; F = 30.72) in SCs' response to chemotactic agents. The Boyden' chamber assay, indeed, indicated that the ALLOexposed SCs were responsive to a chemotactic agent, such as FCS. The number of migrating cells was significantly increased (p < 0.05; F = 78.36) after 24 h treatment with ALLO 10 À6 M. These findings suggested that ALLO makes SCs more responsive to the chemoattractants (Fig. 2e) . The simultaneous co-treatment of SCs for 24 h with ALLO 10 À6 M plus PP2 10 À5 M significantly reduced (p < 0.01; F = 78.36) the response to FCS, still evidencing that Src is involved in the ALLO's induced chemoattractant responsivity of SCs.
ALLO regulates in vitro myelination and internode distance in SCs-DRG neurons co-cultures Previous observations strongly suggested that ALLO increases the levels of some peripheral myelin protein (i.e. glycoprotein P0 and peripheral myelin protein of 22 KDa), thus participating in the control of PNS myelination (Melcangi et al. 1999 (Melcangi et al. , 2000 . Interestingly, we analysed a co-culture system between SCs and DRG sensitive neurons, which represents a reliable experimental model to study in vitro myelination and pharmacological treatments (Fig. 3a) . Therefore, we investigated in vitro the ALLO's capability to regulate myelination. Light microscopy and IFL images (SCs labelled in green, DRG neurons in red) showed that a 21-days treatment with ALLO 10 À6 M stimulates in vitro myelination ( Fig. 3b and c, merge in yellow), when compared with control cocultures. As expected, the simultaneous co-treatment with ALLO 10 À6 M plus PP2 10 À5 M strongly decreased in vitro myelination ( Fig. 3b and c) . We also found that ALLO 10 À6 M treatment significantly (p < 0.05; t = 3.61; F = 3.46) increased the internode distance (Fig. 3d) , ascribing to ALLO a novel important role in SCs physiological processes. These measurements were undetectable in co-culture treated with ALLO plus PP2, given the absence of an estimable in vitro myelination (Fig. 3b) .
ALLO actions in SCs involve the modulation of Src and p-FAK pathways
Given that most of ALLO effects regard the rapid control of SCs proliferation, migration and morphological rearrangements, we investigated the nature of Src and FAK protein kinases, potentially involved in these cytoskeleton reorganization and migration changes. First, we focused our attention on Src. ALLO treatment increased the expression of total Src and p-Src, respectively, after 30 and 60 min; data were normalized for actin (50 kDa) housekeeping protein (Fig. 4a) , which levels from different experiments were within 10% of each other. Quantitative evaluation at 30 min showed a significant decrease in p-Src/ Src ratio (p < 0.05; F = 6.61), likely because of an increase in total Src (Fig. 4b) . Then, at 60 min, a significant increase in pSrc/Src ratio (p < 0.05¸F = 16.69) was observed; this was because of an increase in p-Src (Fig. 4c) . Altogether, these data confirmed a decrease in p-Src/Src ratio at 30 min, then an increase at 60 min, suggesting that ALLO lightly stimulates Src synthesis, in turn inducing its phosphorylation (Fig. 4b) .
Thereafter, we speculated on FAK as a signalling protein downstream Src activation. FAK showed a protein profile in line with Src; indeed, the levels of total p-FAK were increased after 30 and 60 min post ALLO treatment (Fig. 4a) . The quantitative evaluation at 30 and 60 min Medium was replaced and cell proliferation was blocked with 50 ng/mL mitomycin. SCs were photographed at 2 (t 2 h), 6 (t 6 h) and 24 h (t 24 h) after the scratch. (b) Microscopic images of SCs undergoing a scratch on the bottom of the well (t 0 h). Medium was replaced and cell proliferation was blocked by adding 50 ng/mL mitomycin. SCs were treated with ALLO 10 À6 M and analysed at t 2 h, t 6 h and t 24 h. (c) Microscopic images of SCs undergoing a scratch on the bottom of the well (t 0 h). Medium was replaced and cell proliferation was blocked by adding 50 ng/mL mitomycin. Then SCs were treated with ALLO 10 À6 M plus PP2 10 À5 M and analysed at t 2 h, t 6 h and t 24 h. Bar 10 lm. (d) Histograms of cell distance (lm) of SCs treated, respectively, with ALLO 10 À6 M (light dotted columns) or ALLO 10 À6 plus PP2 10 À5 M (grey dotted columns) versus controls (CTR, black columns). Treatments with ALLO produced a significant increase in cell migration (***p < 0.001) at 2, 6 and 24 h, completely restored by the treatment with PP2 10 À5 M (***p < 0.001).
The distance (lm) was calculated as difference between measurements of empty space at time 0 and other time points (2, 6 and 24 h). Data are expressed as the mean AE SEM (N = 3) of 3 independent experiments. Two-way ANOVA using Tukey's multiple comparison post hoc test was used for statistical analysis. F = 30.72 (e) SCs exposure to ALLO significantly increases the responsiveness to the chemotactic agent FCS 1%. Migrating cell number (per well) of SCs treated, respectively, with ALLO 10 À6 M (white column, *p < 0.05) or ALLO 10 À6 M plus PP2 10 À5 M (grey dot column, **p < 0.01) was calculated after 18 h versus controls (CTR, black column). Data are expressed as the mean AE SEM (N = 3) of 3 independent experiments. One-way ANOVA using Tukey's multiple comparison post hoc test was used for statistical analysis. F = 78.36
(after actin normalization) showed a significant increase in p-FAK/FAK ratio (p < 0.05; F = 6.71, 30 min; F = 18.01, 60 min), mainly because of an increase in p-FAK at both time points considered ( Fig. 4d and e) . These results are in agreement with the hypothesis that FAK phosphorylation is likely downstream Src activation.
ALLO modulation of Src and p-FAK pathways partially involves GABA-A dependent mechanisms
To speculate on the receptor mediating the ALLO-dependent activation of Src and FAK, first we focused on Src analysis at 30 min, which proved to be the early time-point showing significant changes. Moreover, trying to mimic ALLO effects via GABA-A receptor, the SCs were treated with muscimol 10 À3 M alone (selective GABA-A agonist) or ALLO 10 À6 M plus bicuculline 10 À4 M (selective GABA-A antagonist) respectively. We found that the muscimol treatment decreased the p-Src levels (Fig. 5a ). The quantitative analysis, after actin normalization, confirmed the significant (p < 0.05; F = 8.92) decrease in p-Src with muscimol, in turn producing a significant decrease in the p-Src/Src ratio (p < 0.05; F = 8.92) (Fig. 5b ). In agreement with data above (see Fig. 4b ), the treatment with ALLO significantly decreased the p-Src/Src ratio (p < 0.05; F = 8.92), supporting the GABA-A mediated inactivation of this pathway (Fig. 5b) . Furthermore, co-treatment with ALLO plus bicuculline counteracted the ALLO's effects on Src and p-Src respectively (Fig. 5a ). Quantitative evaluation (after actin normalization) showed that the p-Src/Src ratio after bicuculline treatment was similar to controls (Fig. 5b) . This data further suggested that ALLO acts via a GABA-A activation. Dealing with FAK, we found a trend similar to that showed above (see Fig. 4d ) after the ALLO exposure (Fig. 5c) . Indeed, after actin normalization, the quantitative analysis showed that ALLO significantly (p < 0.05; F = 14.85) increased the p-FAK and p-FAK/FAK levels (Fig. 5d) . Muscimol 10 À3 M alone did not produce any significant change, suggesting that GABA-A mediated mechanisms should not be involved in this control. The simultaneous treatment with ALLO plus bicuculline 10 À4 M, however, potentiates significantly (p < 0.05; F = 14.85) the ALLO-induced rising of p-FAK and p-FAK/FAK ratio ( Fig. 5d) , suggesting that ALLO may be re-addressed towards different signalling pathways, likely via PR or the putative membrane progesterone receptor (mPR).
ALLO modulation of Src and p-FAK pathways depends by actin remodelling
The qualitative analysis of western immunoblots showed that cytochalasin D, a potent inhibitor of actin polymerization and cytoskeleton remodelling, induced an apparent ALLO's potentiation of Src protein levels (Fig. 6a) . In principle, this effect indicates that changes in actin cytoskeleton might strengthen ALLO's action in SCs. However, the quantitative evaluation of p-Src/Src ratio showed no significant changes following a 30-min ALLO treatment in the presence of cytochalasin D 2 9 10 À6 M (Fig. 6b) . Treatment with ALLO alone, indeed, significantly decreased the pSrc/Src ratio (p < 0.05; F = 3.97). Regarding FAK, a similar qualitative trend was observed (Fig. 6a) ; cytochalasin D treatment induced an increase in p-FAK levels (Fig. 6a) . Quantification of p-FAK and p-FAK/FAK ratio still confirmed the significant stimulation induced by ALLO (p < 0.05; F = 3.86), whereas no change in p-FAK/FAK ratio following cytochalasin D treatment was observed (Fig. 6b) .
Discussion
In this paper, we reported about the molecular mechanisms of ALLO's action in SCs. In particular, we provided evidence that: (i) ALLO controls SCs motility and morphological changes, supporting proliferation [as previously shown (Perego et al. 2012) ] and also inducing myelination, (ii) these processes involve the activation of Src and p-FAK signalling, (iii) ALLO modulation of Src and p-FAK pathways involves GABA-A dependent mechanisms and relies on actin rearrangements. It is known that ALLO, synthesized or metabolized in SCs, participates in the control of myelination, nociception and nerve regeneration (Magnaghi et al. 2006a (Magnaghi et al. , 2010 Magnaghi 2011; Patte-Mensah et al. 2014) . ALLO exerts a stimulatory action on the peripheral myelin protein of 22 kDa levels in vitro (Melcangi et al. 1999; Magnaghi et al. 2006b ), inducing the in vivo myelination in injured adult and aged rats (Melcangi et al. 1999; Azcoitia et al. 2003) . ALLO participates in co-regulating the myelination programme by controlling the expression of important transcription factors, such as Krox-20 and Sox10 (Magnaghi et al. 2007) . In SCs, ALLO takes part in orchestrating these processes by activating integrated mechanisms that involve the GABA synthesis, as well as the GABA-A and GABA-B receptors modulation (Faroni and Magnaghi 2011; Procacci et al. 2012) . Namely, through a PK-A-dependent autocrine loop ALLO stimulates the GABA synthesis (Magnaghi et al. 2010) , while through a GABA-A-activated PK-C-dependent action, ALLO regulates the EAAC1 activity, providing glutamate as GABA precursor in SCs (Perego et al. 2012) . However, other protein kinases, such as PKC-epsilon, seem to be involved in ALLO's effects on SCs. Recently, we suggested that PKC-epsilon may be regulated in DRG neurons by conditioned medium obtained from SCs treated with 10 À6 M ALLO (Puia et al. 2015) ; whether ALLO may alter PKC-epsilon directly in SCs is still under evaluation. ALLO acts mainly through the GABA-A receptor by a concentration-dependent mechanism (Majewska et al. 1986; Rupprecht and Holsboer 1999; Lambert et al. 2003) . In the low nanomolar range ALLO's action is allosteric, enhancing the action of the natural ligand GABA, whereas in the micromolar range, ALLO directly gates the GABA-A receptor channel (Callachan et al. 1987; Puia et al. 1990 ). However, the intrinsic cellular mechanisms regulating most of the ALLO-mediated processes are largely unknown. Therefore, in our paper we speculated on the ALLO's mechanisms that might affect the cellular and biological processes regulating SCs.
Data in the literature evidenced the participation of Src in the control of cell migration and differentiation (Zhao et al. 2003) . In agreement with that capacity of Src, we reported that ALLO might control SCs morphology and motility via a Src signalling. These findings corroborate the importance of Src in the initiation of peripheral myelination (Hossain et al. 2010) .
As previously reported, EAAC1 delivery on the SCs membrane is stimulated by ALLO and prevented by actin depolymerization, suggesting that also EAAC1 participates in the control of the rapid ALLO-mediated effects on SC morphology and proliferation (Perego et al. 2012) . These phenomena are likely exerted because ALLO is able to promote the selective EAAC1 binding to proteins tethering the transporter to the actin cytoskeleton. In SCs, ALLO accumulated actin at the leading edge and in the filopodia, whose number was significantly increased (Perego et al. 2012). In addition, here we proved that, beside EAAC1 involvement, the ALLO's effects on actin rearrangements may involve Src/p-FAK. It is important to underline that in our experimental models, ALLO's effects on actin remodelling did not entail any alteration in the actin protein levels, which remain within 10% variation among samples analysed. Other progestagens were shown to be involved in the control of actin polymerization, branching and FAK complex formation, and these effects seemed to be mediated via the classic PR. Interestingly, these phenomena may be relevant for neuronal plasticity and dendritic spine turnover (Sanchez et al. 2013) . However, the Src/FAK signalling cascade might be implicated in the glial cells functions, albeit it was never entirely studied in these cells, neither in the CNS nor in the PNS. Only FAK was shown to be required for proliferation, spreading and SCs differentiation (Grove et al. 2007; Grove and Brophy 2014) , even if it does not seem to be required by adult SCs for myelin maintenance, nor for re-myelination after nerve injury (Grove and Brophy 2014) . This suggests a role for FAK primarily in SCs development. However, in other models FAK was proved to be downstream Src and upstream moesin activation (Sanchez et al. 2013) .
Altogether, these findings corroborate the hypothesis that the ALLO-mediated GABA-A control of SCs may be responsible for the delayed differentiation observed in vivo, following neuroactive steroid treatment (Melcangi et al. 2000; Azcoitia et al. 2003) .
Beside the GABA-A involvement in the ALLO's mediated changes in SCs, other mechanisms involving the mPRs or the metabotropic GABA-B receptors might participate in regulating some of the SC changes observed. Indeed, our findings showed that Src seems to be controlled directly by ALLO through a GABA-A dependent mechanisms, whereas FAK might be partially regulated via this receptor. Other signalling systems involving the classic PR or the membrane mPR receptors might be also considered as possible FAK regulators. In addition, we do not exclude that some of the effects induced by ALLO might be because of its retro-conversion in dehydroprogesterone and/or progesterone, still interacting with the classic PR or non-classic mPR, steroid receptors. However, our observation that ALLO-mediated effects on proliferation, chemotactic response and myelination are counteracted by the co-treatment with the specific Src inhibitor PP2 seems to exclude such a hypothesis.
Finally, apart the consolidated capability of ALLO in controlling PNS myelination (Melcangi et al. 1999; Azcoitia et al. 2003; Magnaghi et al. 2006b ), we infer that ALLO also regulates the myelination and the internode length. Fig. 7 GABA-A receptor, Src and pFAK activation by Allopregnanolone (ALLO). We corroborate the hypothesis that the neuroactive steroid ALLO is important in regulating the SCs development and maturation. We suggest that almost all these effects are mediated by GABA-A receptor signalling cascade, that induces a Src phosphorylation and in turn a FAK-Tyr397 phosphorylation. However, some potential ALLO's mechanisms involving other membrane receptors, putative membrane progesterone receptor (mPR) or classic PR receptors should be taken in consideration. Altogether, these activations produce SCs cytoskeleton remodelling, migration, chemoattractant responsivity and proliferation.
Although we are not able to determine whether such control is exclusively dependent on Src activation, data from the literature support this relationship. Indeed, SCs from Lck -/-knockout mice (Lck, a lymphoid cell kinase belonging to the Src kinase family) showed shorter and fewer internodes upon myelination, associated to delayed and altered myelination (Ness et al. 2013) . Given that a functional relationship between the internodal length and nerve conduction velocity was proved (Wu et al. 2012) we suggest that ALLO, likely via indirect mechanisms, may have important physiological functions in regulating the nerve conduction velocity in peripheral nerves.
In conclusion, in this study we further proved the importance of the neuroactive steroid ALLO in regulating the SCs development and maturation. In particular, we suggest that these effects are mediated mostly by GABA-A receptor and Src/FAK signalling cascade activation, resulting in SCs actin remodelling, migration, chemoattractant responsivity and proliferation (Fig. 7) . The comprehension of these mechanisms may represent a potential therapeutic approach towards the control of SCs physiological processes and the development of new therapies for the peripheral neuropathies.
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